Oncternal Therapeutics Inc. buy HC Wainwright
Start price
31.05.24
/
50%
€0.32
Target price
31.05.25
€17.46
Performance (%)
-
End price
01.06.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncternal Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.323% | 2.208% | 21.610% |
| iShares Nasdaq 100 | 0.145% | -0.987% | 5.603% |
| iShares Nikkei 225® | 0.091% | -1.421% | 12.897% |
| iShares S&P 500 | 0.371% | -0.469% | 3.470% |
Comments by HC_Wainwright for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Ratings data for ONCT provided by MarketBeat
In the thread Trading Oncternal Therapeutics Inc.
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten
Stopped prediction by HC_Wainwright for Oncternal Therapeutics Inc.
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
12.08.24
12.08.24
€16.48
12.08.25
12.08.25
-
13.08.25
13.08.25
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
13.05.24
13.05.24
€17.59
13.05.25
13.05.25
-
14.05.25
14.05.25
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
15.04.24
15.04.24
€26.28
15.04.25
15.04.25
-
16.04.25
16.04.25
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.32
29.01.24
29.01.24
€27.72
29.01.25
29.01.25
-
30.01.25
30.01.25
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
27.12.23
27.12.23
€1.81
27.12.24
27.12.24
-41.48%
28.12.24
28.12.24

